GlobalData on MSN
FDA accepts Otsuka’s centanafadine application for ADHD treatment
The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.
Add Yahoo as a preferred source to see more of our stories on Google. People with ADHD have trouble with attention, organisation, time management and self-control Attention deficit hyperactivity ...
TwistedSifter on MSN
New study shows that women get an ADHD diagnosis five years later than men, even when their symptoms arise at the same age
Gendered diagnosis screening may be necessary.
ADHD is associated with impulsivity, hyperactivity, and trouble with focus, but kids with ADHD may also struggle with motor ...
Research shows that eating nutritious meals helps the brain function optimally, but numerous social media posts are claiming ...
Emotional outbursts and sudden mood shifts are part of various mental health conditions. Learn what drives this dysregulation ...
Recognizing attention-deficit/hyperactivity disorder symptoms early is important for several reasons. Early identification allows for timely intervention, which can ...
When a condition is seen through a single stereotype, those who don’t fit that picture fall through the cracks ...
This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: ADHD and menopause symptoms can overlap, and one ...
Low" leaned intently over a glowing digital controller, headphones on and head bobbing, as she mixed two tracks by New Order ...
Impulsivity, hyperactivity, and difficulty concentrating are some of the symptoms associated with attention deficit ...
The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results